Genetically Engineered Mice as Experimental Tools to Dissect the Critical Events in Breast Cancer

Adv Cancer Res. 2014;121:331-382. doi: 10.1016/B978-0-12-800249-0.00008-1.

Abstract

Elucidating the mechanism of pathogenesis of breast cancer has greatly benefited from breakthrough advances in both genetically engineered mouse (GEM) models and xenograft transplantation technologies. The vast array of breast cancer mouse models currently available is testimony to the complexity of mammary tumorigenesis and attempts by investigators to accurately portray the heterogeneity and intricacies of this disease. Distinct molecular changes that drive various aspects of tumorigenesis, such as alterations in tumor cell proliferation and apoptosis, invasion and metastasis, angiogenesis, and drug resistance have been evaluated using the currently available GEM breast cancer models. GEM breast cancer models are also being exploited to evaluate and validate the efficacy of novel therapeutics, vaccines, and imaging modalities for potential use in the clinic. This review provides a synopsis of the various GEM models that are expanding our knowledge of the nuances of breast cancer development and progression and can be instrumental in the development of novel prevention and therapeutic approaches for this disease.

Keywords: Breast cancer; Genetically engineered mouse (GEM) models; Transgenic animals.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Breast Neoplasms / pathology*
  • Cell Proliferation
  • Cell Transformation, Neoplastic / genetics*
  • Disease Models, Animal*
  • Female
  • Humans
  • Mammary Glands, Animal / pathology
  • Mammary Glands, Animal / physiology
  • Mice*
  • Mice, Transgenic
  • Signal Transduction / genetics